Editorial: Intestinal Dysbiosis in Inflammatory Diseases

Front Immunol. 2021 Jul 30:12:727485. doi: 10.3389/fimmu.2021.727485. eCollection 2021.

Gislane Lelis Vilela de Oliveira^{1

2}, Cristina Ribeiro de Barros Cardoso³, Veena Taneja⁴, Alessio Fasano^{5

6

7}

¹ Microbiology Program, Institute of Biosciences, Humanities and Exact Sciences, São Paulo State University, Sao Jose do Rio Preto, Brazil.
² Department of Food Engineering and Technology, Institute of Biosciences, Humanities and Exact Sciences, São Paulo State University, Sao Jose do Rio Preto, Brazil.
³ Department of Clinical Analysis, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
⁴ Department of Immunology and Department of Medicine, Division of Rheumatology, Mayo Clinic Rochester, Rochester, MN, United States.
⁵ Division of Pediatric Gastroenterology and Nutrition, Center for Celiac Research, Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA, United States.
⁶ Gastroenterology and Nutrition, Harvard Medical School, Boston, MA, United States.
⁷ European Biomedical Research Institute of Salerno, Salerno, Italy.

No abstract available

Keywords: dysbiosis; gut microbiota; gut permeability; inflammatory diseases; microbiota modulators.

Publication types